Stay updated on Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-14T19:53:19.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T20:38:31.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    - The page now renders a 403 Forbidden error page with a minimal header and a Home link, replacing the study content. This indicates the study page is currently inaccessible rather than displaying the expected record details.
    Difference
    22%
    Check dated 2026-09-23T22:02:52.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    Added the disease keyword 'Multiple myeloma' and a related topics section (including MedlinePlus Genetics) and updated the page's revision label to v3.7.0. The older revision label v3.6.6 was removed.
    Difference
    0.1%
    Check dated 2026-09-16T20:07:38.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 was added and the previous tag v3.6.5 was removed. This indicates a small update to the page's revision history and metadata.
    Difference
    0.0%
    Check dated 2026-09-02T18:23:20.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    An NIH grant/contract identifier (2015) was added to the study's identifiers section. This links the trial to its funding source and improves record completeness.
    Difference
    0.0%
    Check dated 2026-08-26T19:48:21.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.